grainnequinnpoa

0001585364-24-000021.txt : 20240307 0001585364-24-000021.hdr.sgml : 20240307 20240307210041 ACCESSION NUMBER: 0001585364-24-000021 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20240305 FILED AS OF DATE: 20240307 DATE AS OF CHANGE: 20240307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Quinn Grainne CENTRAL INDEX KEY: 0001679915 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36353 FILM NUMBER: 24732124 MAIL ADDRESS: STREET 1: PERRIGO COMPANY PLC STREET 2: 515 EASTERN AVENUE CITY: ALLEGAN STATE: MI ZIP: 49010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PERRIGO Co plc CENTRAL INDEX KEY: 0001585364 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: THE SHARP BUILDING STREET 2: HOGAN PLACE CITY: DUBLIN 2 STATE: L2 ZIP: D02 TY74 BUSINESS PHONE: 269-673-8451 MAIL ADDRESS: STREET 1: 515 EASTERN AVENUE CITY: ALLEGAN STATE: MI ZIP: 49010 FORMER COMPANY: FORMER CONFORMED NAME: PERRIGO Co Ltd DATE OF NAME CHANGE: 20130828 4 1 wk-form4_1709863230.xml FORM 4 X0508 4 2024-03-05 0 0001585364 PERRIGO Co plc PRGO 0001679915 Quinn Grainne PERRIGO COMPANY PLC 515 EASTERN AVENUE ALLEGAN MI 49010 0 1 0 0 EVP, Chief Medical Officer 0 Ordinary Shares 2024-03-05 4 M 0 1583 27.26 A 15646 D Ordinary Shares 2024-03-05 4 F 0 824 27.26 D 14822 D Ordinary Shares 2024-03-05 4 A 0 9028 27.26 A 23850 D Ordinary Shares 2024-03-05 4 F 0 4695 27.26 D 19155 D Restricted Stock Units 2024-03-05 4 M 0 1583 D Ordinary Shares 1583 0 D Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022. /s/ Victor Torres, attorney-in-fact for Ms. Grainne Quinn 2024-03-07 EX-24 2 grainnequinnpoa.htm EX-24 grainnequinnpoa

The undersigned hereby constitutes and appoints each of Todd W. Kingma, Ryan Bradtke and Victor Torres, signing singly, as the undersigned’s true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director of Perrigo Company plc (the “Company”), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do any and all things and take any and all actions necessary in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of _9/29/2020

Grainne Quinn EVP, Chief Medical Officer